The shikonin derivatives, accumulated in the roots of Arnebia euchroma (Boraginaceae), showed antibacterial, anti-inflammatory, and anti-tumor activities. To explore their possible biosynthesis regulation mechanism, this paper investigated the effects of exogenous methyl jasmonate (MJ) on the biosynthesis of shikonin derivatives in callus cultures of A. euchroma. The main results include: Under MJ treatment, the growth of A. euchroma callus cultures was not inhibited, but the expression level of both the genes involved in the biosynthesis of shikonin derivatives and their precursors and the genes responsible for intracellular localization of shikonin derivatives increased significantly in the Red Strain (shikonin derivatives high-producing strain). The quantitative analysis showed that six out of the seven naphthoquinone compounds under investigation increased their contents in the MJ-treated Red Strain, and in particular, the bioactive component acetylshikonin nearly doubled its content in the MJ-treated Red Strain. In addition, it was also observed that the metabolic profiling of naphthoquinone compounds changed significantly after MJ treatment, and the MJ-treated and MJ-untreated strains clearly formed distinct clusters in the score plot of PLS-DA. Our results provide some new insights into the regulation mechanism of the biosynthesis of shikonin derivatives and a possible way to increase the production of naphthoquinone compounds in A. euchroma callus cultures in the future.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12010-014-1025-9DOI Listing

Publication Analysis

Top Keywords

shikonin derivatives
28
biosynthesis shikonin
16
callus cultures
12
red strain
12
naphthoquinone compounds
12
effects exogenous
8
exogenous methyl
8
methyl jasmonate
8
jasmonate biosynthesis
8
derivatives callus
8

Similar Publications

Article Synopsis
  • Gliomas are the most common type of brain tumors with high malignancy, fast recurrence, and high mortality rates, and current treatments have limited success.
  • Shikonin, a compound from traditional Chinese medicine, has shown effectiveness against gliomas by inducing a type of cell death called necroptosis and reducing markers associated with cancer stem cells.
  • The study explores how Shikonin impacts the proteasome activity and immune proteasome subunits in glioma cells, suggesting its potential as a new treatment option for dealing with these challenging tumors.
View Article and Find Full Text PDF

Trametinib and M17, a novel small molecule inhibitor of AKT, display a synergistic antitumor effect in triple negative breast cancer cells through the AKT/mTOR and MEK/ERK pathways.

Bioorg Chem

November 2024

State Key Laboratory of Pharmaceutical Biotechnology, Institute of Plant Molecular Biology, School of Life Sciences, Nanjing University, Nanjing 210023, China; Co-Innovation Center for Sustainable Forestry in Southern China, Nanjing Forestry University, Nanjing 210037, China. Electronic address:

Triple negative breast cancer (TNBC) is associated with a poor prognosis and limited response to traditional chemotherapy, necessitating the exploration of novel treatment approaches. Recent researches have highlighted the interconnected roles of the PI3K/AKT pathway and MAPK pathway in TNBC cells, contributing to the efficacy of treatments. Therefore, the concurrent inhibition of both pathways presents a potential new therapeutic strategy for TNBC patients.

View Article and Find Full Text PDF

Background: Breast cancer seriously affects physical and mental health of women. Despite advances in the clinical use of different treatments, breast cancer remains a major cause of mortality. Therefore, it is imperative to identify promising treatment options.

View Article and Find Full Text PDF

This study presents biomimetic nanoscaffolds composed of electrospun polycaprolactone-collagen (PCL-Coll) nanofibers, loaded with bioactive Arnebia euchroma (AE) extract and stem cells, to develop cell-based tissue engineering constructs. The incorporation of AE extract, known for its antioxidant and anti-inflammatory properties, into the PCL-Coll nanofibers resulted in nanoscaffolds denoted as PCL-Coll/AE, PCL-Coll/AE, PCL-Coll/AE, and PCL-Coll/AE, corresponding to AE extract concentrations of 0.0, 5.

View Article and Find Full Text PDF
Article Synopsis
  • Pro-inflammatory macrophages (M1) play a crucial role in rheumatoid arthritis (RA) by producing high levels of cytokines, and shifting them to a pro-resolving M2 phenotype can help restore immune balance.
  • The study uses liquid nitrogen-treated dead macrophages as a drug carrier for shikonin (SHK), which activates AMPK and promotes efferocytosis, transforming M1 macrophages into M2 macrophages.
  • This treatment in a mouse model of collagen-induced arthritis shows a significant reduction in inflammation and tissue damage by enhancing the production of anti-inflammatory mediators and protecting cartilage and bone.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!